Photo: Reuters
Investing.com -- U.K. regulators flag allergic reactions to the Pfizer/BioNTech vaccine. DoorDash raises nearly $3.4 billion in a blockbuster initial public offering (IPO) and AirBnB is expected to price later. Stocks edge up as politicians continue stimulus dance and the yuan hits new highs despite inflation dipping below zero for the first time in a decade.
1. Pfizer allergic reaction
U.K. health regulators warned that people suffering from allergy issues should not take the vaccine developed by Pfizer and BioNTech, after two British healthcare professionals experienced allergic reactions to the drug after being inoculated earlier in the week. Both carers are recovering well, according to an official from the National Health Service for England.
The news comes only two days after the U.K. began a mass immunization program using the drug, and a day after the U.S. Food and Drug Administration (FDA) said it had found no safety issues in an analysis of data from the companies’ stage 3 trial. The FDA is expected to approve the drug for emergency use at a meeting on Thursday.
2. DoorDash and AirBnB pricings
DoorDash priced its initial public offering at $102 a share, well above a marketing range that had already been revised upward, according to various reports.
That means the food delivery company will raise a total of $3.4 billion and gives it an overall valuation of $39 billion, more than double what it was valued at in a private round of fundraising earlier this year.
3. Stocks set to open higher; stimulus talks ongoing
U.S. stock markets are set to open mostly higher, supported by signs that the U.S. is edging closer to agreeing a fiscal package to lighten the burden on the economy from the latest wave of the Covid-19 pandemic.
Read more from the original article:
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.